{
    "2020-07-23": [
        [
            {
                "time": "",
                "original_text": "涨，停，潮！疫苗连传好消息，下半年医改重点任务已敲定",
                "features": {
                    "keywords": [
                        "涨停",
                        "疫苗",
                        "医改",
                        "下半年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|点评】昭衍新药拟H股上市，在岸外包业务的必然选择",
                "features": {
                    "keywords": [
                        "昭衍新药",
                        "H股上市",
                        "外包业务"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|外包周报】A+H加速布局下医药CXO板块，是否还可以加仓？",
                "features": {
                    "keywords": [
                        "A+H布局",
                        "医药CXO",
                        "加仓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】持续关注Q2基金重仓提升的制药创新产业链─医药行业周报",
                "features": {
                    "keywords": [
                        "Q2基金重仓",
                        "制药创新",
                        "产业链"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "制药创新"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}